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Abstract 
 
Marine animals and plants are rich sources of bioactive natural products. Haterumalides and biselides, 
isolated from Okinawan marine animals, are 14-membered macrolides with strong cytotoxicity 
against human cancer cell lines. This review highlights the isolation, structures, bioactivities, and 
total synthesis of haterumalides, biselides, and related natural products. 
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Introduction 
 
Marine animals and plants are rich sources of bioactive natural products.1 The search for antitumor 
substances from marine organisms has been conducted worldwide, and many cytotoxic and/or 
antitumor marine natural products have been isolated, some of which are promising for anticancer 
chemotherapy. Some examples are halichondrin B, discodermolide, and cryptophycin from sponges; 
didemnin B, aplidine, and ecteinascidin 743 from ascidians; bryostatin 1 from a bryozoan; and 
dolastatin 10 and kahalalide F from sea hare. Because many of these compounds were isolated from 
tropical or subtropical seas, marine organisms in tropical and subtropical zones have attracted the 
interest of natural product chemists and pharmaceutical scientists. 
 
Isolation and Biological Activities of Haterumalides, Biselides, and Related Compounds 
 
In 1999, the first haterumalide family was isolated from an Okinawan ascidian by Ueda and Hu2 and 
from an Okinawan sponge by Uemura and coworkers (Figure 1).3 Ueda and Hu isolated haterumalide 
B (6) from the Okinawan ascidian Lissoclinum sp. and determined the structure with partial 
stereochemistry spectroscopically. Haterumalide B (6) completely inhibited the first cleavage of 
fertilized sea urchin eggs at a concentration of 0.01 µg/mL. At the same time, Uemura and coworkers 
isolated haterumalides NA (1), NB (2), NC (3), ND (4), and NE (5) from the Okinawan sponge 
Ircinia sp. Although these compounds were isolated as very minute components of the animal, they 
helped elucidate the absolute stereostructure of haterumalide NA (1) by detailed spectroscopic 
analysis and the modified Mosher method,4 as shown in structural formula 1. Later, they revised the 
relative stereochemistry and determined the absolute stereochemistry of haterumalide NA in an 
organic synthetic manner.5 Haterumalide NA (1) exhibited cytotoxicity against P388 cells, with an 
IC50 of 0.32 µg/mL, and moderate acute toxicity against mice, with an LD99 of 0.24 g/kg. 
That same year, an anti-oomycete compound, oocydin A (12), was isolated from South American 
epiphyte Serratia marcescens by Strobel and coworkers.6 The gross structure with partial 
stereochemistry was determined by spectroscopic analysis. 
Thaning and coworkers screened 300 bacterial isolates for the ability to suppress apothecial 
formation of Sclerotinia sclerotiorum and isolated haterumalide NA/oocydin A from the soil 
bacterium Serratia plymuthica as an active compound.7  
Levenfors and coworkers isolated haterumalide X from the soil bacterium Serratia plymuthia along 
with haterumalides NA (1), B (6), and NE (5).8 Haterumalide X was found to be the Z isomer of the 
C16 double bond in haterumalide NA (1). They could not collect antifungal data on haterumalide X 
because this compound is easily converted into haterumalide NA (1). 
Later, researchers at Fujisawa Pharmaceutical Company isolated an antimicrobial component, 
FR177391 (13), from the soil bacterium Serratia liquefaciens. The structure was determined by 
X-ray crystallographic analysis of the propylamide derivative.9 This compound is the enantiomer of 
haterumalide NA (1). They reported on a detailed study of its anti-hyperlipidemic activity10 and the 
microbial conversion into 20-hydroxy FR177391 (14).11 In addition, they identified its molecular 
target as protein phosphatase 2A (PP2A).12 
It is notable that haterumalides NA (1) and B (6), which are marine natural products, are levorotatory, 
while oocydin A (12) and FR177391 (13) from an epiphyte of an aquatic plant and a soil bacterium 
are dextrorotatory.  
In 2004, Kigoshi and coworkers isolated biselides A (7) and B (8), oxygenated analogs of 
haterumalides, from the Okinawan ascidian Didemnidae sp. and determined their structures by 
detailed spectroscopic analysis (Figure 1).13 The next year, they reported the isolation of three more 
analogs, biselides C (9)-E (11) and compared the cytotoxicity of biselides A (7) and C (9) with that of 
haterumalide NA methyl ester (15).14 The order of the cytotoxicity is haterumalide NA methyl ester 
(15) > biselide A (7) > biselide C (9). Among the tested cell lines, biselide A (7) showed the strongest 
cytotoxicity against human colon cancer DLD-1 (0.513 µΜ). Interestingly, haterumalide NA (1) 
showed strong toxicity against brine shrimp, with an LD50 of 0.6 µg/mL, while biselides A (7) and C 
(9) showed no toxicity against brine shrimp, even at 50 µg/mL. It is worth noting that 20-hydroxy 
FR177331 (14), the microbial oxidation compound of FR177331 (13), has the same planar structure 
as biselide C (9). 
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Figure 1. Structures of haterumalides and biselides 
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Figure 2. Structures of oocydin A, FR177391, and 20-hydroxy FR177391 
 
Synthetic Studies of Haterumalides 
 
Studies in Kigoshi’s Laboratory 
The first report concerning haterumalides from the Kigoshi laboratory described an enantioselective 
synthesis of ent-haterumalide NA methyl ester (15).5 This synthesis revised the stereochemistry of 
haterumalide NA and determined its absolute stereochemistry. 
Their synthetic route to ent-haterumalide NA methyl ester (15) involved a key macrocyclization at 
C2-C3 using an intramolecular Reformatsky-type reaction (Scheme 1). They also developed a 
coupling between aldehyde 16 and iodoolefin 17 at C15-C16 using a Nozaki-Hiyama-Kishi 
coupling.15  
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Scheme 1. Strategy for the synthesis of haterumalide NA methyl ester developed by Kigoshi et al. 
MPM, pmethoxyphenylmethyl; FAMSO, formaldehyde dimethyldithioacetal S-oxide. 
  
 
The starting point for this work was the construction of the tetrahydrofuran unit (Scheme 2). 
Mono-MPM ether 22 was synthesized from commercially available 
(+)-2,3-O-isopropylidene-L-threitol. After transformation into the corresponding iodide, C1 
homologation was achieved by using the FAMSO carbanion to afford sulfoxide 23. Sequential acidic 
methanolysis and hydrolysis afforded a hemiacetal 24. The Wittig reaction of 24 and cyclization 
provided a 5.3:1 diastereomeric mixture of tetrahydrofurans, which were separated after silylation to 
afford the desired trans-tetrahydrofuran 26 and cis-isomer. The latter was isomerized into a 1:1 
mixture under basic conditions. The desired trans-tetrahydrofuran 26 was quantitatively converted 
into bromide 21 in three steps.  
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Scheme 2. Synthesis of trans-2,5-dialkyl tetrahydrofuran unit according to Kigoshi et al. TMS, 
trimethylsilyl; THP, tetrahydropyranyl; MPM, p-methoxyphenylmethyl; TBS, 
tert-butyldimethylsilyl; HMPA, hexamethylphosphoramide; NCS, N-chlorosuccinimide; DMF, 
N,N-dimethylformamide; KHMDS, potassium hexamethyldisilazane; DIBAL, diisobutylaluminium 
hydride; MMTr, p-methoxyphenyldiphenylmethyl. 
 
The coupling reaction between the tetrahydrofuran unit 21 and a carbanion generated from 
Z-alkenylsilane 20 gave alkenylsilane 19 (Scheme 3). The stereoselective construction of a 
chloroolefin unit from alkenylsilane 19 was achieved by a modification of Tamao’s procedure16 for 
conversion of an alkenylsilane to a bromoolefin. Kigoshi et al. found that the addition of a catalytic 
amount of water was important for the reaction to be reproducible. Acidic hydrolysis of 27 and 
subsequent Dess-Martin oxidation afforded a labile aldehyde, which was converted into the 
Z-conjugated ester 28 by using the Still-modified Horner-Wadsworth-Emmons reaction.17 The 
DIBAL reduction of 28 gave an allylic alcohol, the hydroxy group of which was protected as an 
MMTr ether to afford compound 29 quantitatively. The silyl group in 29 was removed, and the 
resulting alcohol was converted into a bromo ester. The MMTr group was removed, and the resulting 
allylic alcohol was oxidized to afford the conjugated aldehyde 18, a precursor of the intramolecular 
Reformatsky-type reaction. 
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Scheme 3. Synthesis of the C3-C15 segment of haterumalide NA methyl ester according to Kigoshi et 
al. TMS, trimethylsilyl; THP, tetrahydropyranyl; MPM, p-methoxyphenylmethyl; TBS, 
tert-butyldimethylsilyl; HMPA, hexamethylphosphoramide; NCS, N-chlorosuccinimide; DMF, 
N,N-dimethylformamide; KHMDS, potassium hexamethyldisilazane; DIBAL, diisobutylaluminium 
hydride; MMTr, p-methoxyphenyldiphenylmethyl. 
 
Cyclization under Honda’s conditions,18 Et2Zn-RhCl(PPh3)3, followed by the addition of Ac2O to 
trap the reactive products afforded the desired cyclized product in 9% yield along with the (3R, 4Z) 
and (4E) isomers (Scheme 4). The MPM group was removed to give alcohol 30. The 
Nozaki-Hiyama-Kishi coupling reaction of iodide 17 and aldehyde 16 derived from 30 afforded the 
coupling product 15 (57%, S:R = 11:1). The major isomer, (15S)-15, was found to be the enantiomer 
of the naturally occurring haterumalide NA methyl ester 15 upon comparison of their spectral data. 
These results determined the total absolute stereochemistry, which revised the proposed structure.  
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Scheme 4. Synthesis of ent-haterumalide NA methyl ester according to Kigoshi et al. DDQ, 
2,3-dichloro-5,6-dicyano-1,4-benzoquinone; Ac, acetyl. 
 
Studies in Snider’s Laboratory 
Snider et al. reported the total synthesis of ent-haterumalide NA methyl ester (15).19 Their strategy 
involved a key fragment coupling at C5-C6 using a Stille coupling (Scheme 5).20 They also 
accomplished macrocyclization of a seco acid by Yamaguchi conditions.21  
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Scheme 5. Strategy for the synthesis of haterumalide NA methyl ester developed by Snider et al. 
 
The synthetic route reported by Snider begins with the preparation of optically active vinylstannane 
33 (Scheme 5). The Z-methyl-substituted alkene unit 36 was prepared by the Cu-catalyzed 
methylmagnesation of propargyl alcohol 3522 followed by iodinolysis. Iodoalkene 36 was oxidized 
with MnO2 to afford an iodoaldehyde. The asymmetric aldol reaction of the iodoaldehyde with the 
ketene silyl acetal 37 by using Kiyooka’s oxaborolidinone 38 provided the β-hydroxy phenyl ester 
39.23 The allylic hydroxyl group of 39 was protected as a TBS ether, and the resulting vinyl iodide 
was converted into the vinylstannane 33. 
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Scheme 6. Synthesis of vinylstannane 33 according to Snider et al. TMS, trimethylsilyl; TBSOTf, 
trifluoromethanesulfonic acid tert-butyldimethylsilyl ester; i-Pr2NEt, N,N-diisopropylethylamine; 
TBS, tert-butyldimethylsilyl. 
 
In contrast, an optically active alcohol 34 was prepared via an asymmetric aldol reaction between the 
O-TMS dienolate 40 and acrolein (41) by using Carreira’s Ti(IV) catalyst 42,24 or kinetic resolution 
of the racemic alcohol 43 via Sharpless asymmetric epoxidation (Scheme 7).25  
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Scheme 7. Synthesis of optically active diol 34 according to Snider et al. TMS, trimethylsilyl; TBHP, 
tertbutylhydroperoxide; DIPT, diisopropyl tartrate; MS4A, molecular sieves 4A. 
 
Alcohol 34 was converted to a keto ester, the stereoselective reduction of which with Et2BOMe and 
NaBH4 afforded syn diol 44 (Scheme 8). Diol 44 was protected as an acetonide, and the ester group 
was transformed into an alkyl iodide group in a sequence of reactions to afford iodide 45. The 
coupling reaction between iodide 45 and acetylide 46 generated from the tert-butyldimethylsilyl 
propargyl ether gave a coupling compound (92%). The acetonide group was removed to give diol 47 
by using BF3·OEt2 and propanedithiol. The stereoselective intramolecular iodoetherification of 47 
afforded iodomethyltetrahydrofuran 48 (81%) in >90% de. After acetylation of the secondary 
hydroxyl group, the iodomethyl group was transformed into the desired hydroxymethyl group by 
using m-CPBA, and the acetyl group was cleaved to afford diol 49. Diol 49 was protected as an 
acetonide, and the TBS group was removed to give the propargylic alcohol. A regioselective 
hydroalumination of the propargylic alcohol by using Red-Al® and subsequent treatment with NCS 
furnished the desired Z-chloro allylic alcohol. Reaction of the allylic alcohol with MsCl, Et3N, and 
then LiCl afforded dichloride 32.  
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Scheme 8. Synthesis of Stille coupling precursor 32 according to Snider et al. TBS, 
tert-butyldimethylsilyl; HMPA, hexamethylphosphoramide; m-CPBA, m-chloroperbenzoic acid; 
PPTS, pyridinium p-toluenesulfonate; TBAF, tetrabutylammonium fluoride; Red-Al®, sodium 
bis(2-methoxyethoxy)-aluminium hydride; NCS, N-chlorosuccinimide. 
  
A Stille coupling reaction20 between dichloride 32 and vinylstannane 33 with Pd2dba3 and AsPh3 
afforded 50 (65%) and the corresponding (E)-isomer (Scheme 9). The acetonide group was removed 
by using CSA to give a diol, and selective tritylation of the primary hydroxy group in the diol and 
hydrolysis of the phenyl ester afforded the seco acid 31. The macrolactonization of 31 was 
accomplished by the Yamaguchi method21 to give the desired lactone 51 along with the dimer and the 
trimer. The TBS group in 51 was removed, and the resulting alcohol was converted into an acetate. 
The trityl group was removed to give the primary alcohol 30, which is the key intermediate in 
Kigoshi’s synthesis.5 From this point on, the earlier synthesis was followed. Oxidation with 
Dess-Martin periodinane and Nozaki-Hiyama-Kishi coupling15 with iodide 17 afforded 30-40% of 
haterumalide NA methyl ester (15) after HPLC purification.  
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Scheme 9. Synthesis of ent-haterumalide NA methyl ester according to Snider et al. CSA, 
camphorsulfonic acid; Tr, triphenylmethyl; DMAP, 4-(dimethylamino)pyridine; TBAF, 
tetrabutylammonium fluoride; Ac, acetyl. 
 
Studies in Hoye’s Laboratory 
Hoye et al. first achieved the total synthesis of haterumalide NA (1) itself.26 Their synthetic route to 
haterumalide NA involved a key intramolecular cyclization at C6-C7, based on the Kaneda reaction27 
(Scheme 10).  
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Scheme 10. Strategy for the synthesis of haterumalide NA developed by Hoye et al. 
 
Kaneda et al. reported PdX2-catalyzed coupling reactions of terminal alkynes with allylic chlorides 
and bromides to produce crossed 1:1 adducts (Scheme 11). The catalytic cycle for the Kaneda 
reaction has three steps: 1) cis-addition of the PdX2-catalyst into alkyne; 2) allylic halide inserts into 
a Pd-vinyl bond; and 3) β-elimination to give a crossed 1:1 adduct.  
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Scheme 11. Mechanism of the Kaneda reaction 
 
The synthetic route reported by Hoye begins with the preparation of a 3-hydroxy tetrahydrofuran 
derivative by Roush’s method (Scheme 12).28 The [3+2] annulation of the allylsilane 57 with 
α-(p-methoxybenzyloxy)acetoaldehyde 56 was performed using SnCl4 as the Lewis acid catalyst to 
provide the 2,5-trans-substituted tetrahydrofuran 58. The TBS groups in 58 were removed, and the 
resulting diol was converted into an acetonide. The phenyldimethylsilyl group was oxidized by 
Tamao-Woerpel oxidation29 to provide a secondary alcohol. After inversion of the resulting 
secondary alcohol under Mitsunobu conditions,30 the MPM ether group was converted into a 
propargyl group to give compound 53. Esterification between 53 and allylic chloride 54 afforded 
ene-yne 52. This ene-yne compound 52 was a precursor of the Kaneda reaction.  
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Scheme 12. Synthesis of Kaneda reaction precursor 52 according to Hoye et al. MS4A, molecular 
sieves 4A; MPM, p-methoxyphenylmethyl; TBS, tert-butyldimethylsilyl. 
 
The intramolecular macrocyclization of 52 was accomplished by the Kaneda reaction to give the 
desired 14-membered macrolactone 59 (Scheme 13). This compound 59 has the desired 
stereostructure at the Z-∆7,8-alkene, but the ∆4,5-alkene was produced as a separable mixture of the 
isomers. Reduction of the C-3 ketone in the Z-isomer of 59 under Luche conditions gave an alcohol 
as the desired single diastereomer. Acetylation of the resulting hydroxyl group and removal of the 
MPM group gave alcohol ent-30, which is the intermediate in Kigoshi’s route.5  
To convert ent-30 into haterumalide NA, they followed Kigoshi’s procedure5 with a modification. 
Oxidation with Dess-Martin periodinane and Nozaki-Hiyama-Kishi coupling15 with the MPM ester 
60 afforded haterumalide NA MPM ester 61. The MPM ester in 61 was cleaved with TFA and Et3SiH 
to afford haterumalide NA (1).  
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Scheme 13. Total synthesis of haterumalide NA according to Hoye et al. MPM, 
p-methoxyphenylmethyl; DMAP, 4-(dimethylamino)pyridine; DDQ, 
2,3-dichloro-5,6-dicyano-1,4-benzoquinone; Ac, acetyl; TFA, trifluoroacetic acid. 
 
Conclusion 
 
Although marine natural products are regarded as promising sources of drug discovery, the limited 
supply of compounds prevents their development as medicines. Haterumalides and biselides are new 
types of cytotoxic compounds in minute quantities. The studies discussed in this review develop 
efficient synthetic routes to enable further biological and preclinical evaluations of these compounds. 
From a synthetic perspective, it is interesting to note that three syntheses employed different 
strategies to construct a 14-membered macrolactone ring.  
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